XM does not provide services to residents of the United States of America.

HCA Healthcare misses quarterly profit estimates, forecasts up to $300-million hit in Q4



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 3-Hospital operator HCA's quarterly profit dented by hurricane hit; shares slide</title></head><body>

Adds peers' shares in paragraph 5, analyst comment in paragraph 6, 2024 forecast in paragraph 9

Oct 25 (Reuters) -HCA Healthcare HCA.N reported lower-than-expected quarterly profit on Friday and forecast up to a $300-million hit in the fourth quarter due to delays in medical procedures from recent hurricanes, causing its shares to drop 9%.

Hospitals in the direct path of the hurricanes postponed procedures, further strained by IV fluid shortages due to flooding at a major U.S. facility.

HCA, the largest for-profit U.S.hospital operator, said it experienceda loss of revenue in the third quarter ended Sept. 30 fromthe impact of Hurricane Helene on some of its facilities in Florida, Georgia and North Carolina.

Itexpects expenses and revenue lossbetween $200 million and $300 million in the fourth quarter due to a hit from HurricanesHelene and Milton, it said.

Shares of other hospital operators, Tenet Healthcare THC.N and Universal Health Services UHS.N, also fell, by 6% and 8%, respectively, in early trading.

However, the impact from the hurricanes "does not change the long-term fundamental growth outlook of HCA", according to Baird analyst Michael Ha.

The company closed five hospitals in Florida earlier this month in preparation for Hurricane Milton and transferred about 400 patients throughout the state to mandatory evacuation zones.

HCA expects a "manageable" hitfrom Hurricane Helene on its North Carolina facilities even next year. It forecast 2025 profit to be near or slightly above the upper end of its long-term growth range.

It expects its 2024 profit and revenue forecasts to be in the "lower half of the ranges provided", due to lingering effects from the hurricanes.

HCA's quarterly revenue of $17.49 billion missed an estimate of $17.54 billion, according to data compiled by LSEG.

The company reportedthird-quarter profit of $4.88per share. Analysts on average had expecteda profit of $4.97per share.



Reporting by Christy Santhosh in Bengaluru; Editing by Pooja Desai

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.